A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples